Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
Launched by MEDICAL UNIVERSITY OF WARSAW · Oct 18, 2013
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
Nosocomial diarrhea is a common problem in hospitalized children. Previously, it has been documented that the administration of L reuteri DSM 17938 at a dose of 10(8) colony forming units (CFU) compared with placebo had no effect on the overall incidence of nosocomial diarrhea (Wanke \& Szajewska, J Pediatr 2012). Whether higher doses of L reuteri DSM 17938 have such effects needs to be substantiated in further randomized trials.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 1-48 mo admitted to the hospital for reasons other than diarrhea
- • Signed informed consent.
- Exclusion Criteria:
- • Acute gastroenteritis within 3 days before admission
- • Symptoms other than diarrhea suggesting gastroenteritis
- • Use of probiotics within 7 days before admission
- • Immunodeficiency disorders
- • Breastfeeding \>50%
- • Underlying gastrointestinal tract disorder
- • Malnutrition (weight/high \<3pc)
About Medical University Of Warsaw
The Medical University of Warsaw is a leading academic institution dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to excellence in medical training and clinical practice, the university actively engages in a diverse range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. With a robust infrastructure and a multidisciplinary team of experts, the Medical University of Warsaw fosters collaboration in the development of novel therapies and interventions, contributing significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, , Poland
Patients applied
Trial Officials
Hanna Szajewska, MD, Profesor
Principal Investigator
Medical University of Warsaw
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials